Sentinel lymph node detection in gynecologic cancer

Sentinel lymph node detection in gynecologic cancer - Sentinel lymph node detection in gynecologic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024607

Enrollment

Registered

2016-12-01

Start date

2016-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer Cervical cancer

Interventions

A Day before the operation Inject 99mTc-Phytate or 99mTc-Tin colloid to uterine cervix/uterus body The day of the operation Inject 1% patent blue or indocyanine green to uterine cervix/uterus bo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Endometrial cancer clinical stage 1A-2 Cervical cancer clinical stage 1A-2B

Exclusion criteria

Exclusion criteria: 1: Allergy career; 99mTc-Phytate, 99mTc-Tin colloid , 1% patent blue, indocyanine green 2: A pregnant woman, a nursing woman and the patient who may be pregnant 3: The patient whom we judged to be inappropriate as a study subject

Design outcomes

Primary

Measure	Time frame
In endometrial cancer and cervical cancer cases, we detect sentinel lymph node in pre/peri operation	—

Countries

Japan

Contacts

Public ContactYusuke Butsuhara

Kansai Medical University Department of obstetrics and gynecology

gigi1juvejp@yahoo.co.jp0728040101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026